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iAppropriate” cardiovascular (CV) care used to be solely in
he head of the beholder. Before the advent of CV diag-
ostic breakthroughs, physicians relied on intuition and
last case result” to sort out individual treatment. Universal
est practices based on evidence were a dream.
But now we are operating in a wondrous era. We have
eveloped excellent CV patient care protocols that capitalize
n captured collective data and outcomes, in the belief that
e can learn from each other without stumbling through the
ocks ourselves. In the past 20 years, we have seen:
deaths due to acute myocardial infarction reduced by
one-half (1);
echocardiography, nuclear perfusion imaging, and cardiac
catheterization become virtually ubiquitous;
computed tomography (CT) and magnetic resonance
imaging (MRI) added to our arsenal to help us better
understand cardiac pathophysiology;
percutaneous coronary intervention (PCI) become dura-
ble and definitive therapy; and
congestive heart failure yielding to evolutionary life-
saving medical therapy combined with innovative use of
implantable cardioverter defibrillators, resynchronization
pacing therapy, and left ventricular assist devices.
These advances—translated into wonderful care guide-
ines—come just in time, as the “perfect storm” of aging
aby boomers and the growing epidemics of obesity and
iabetes gather on the horizon. Yet, consistently applying
his clinically helpful power “on the ground” is easier said
han done. Study after study documents wide and pervasive
aps between what our College upholds as state-of-the-art,
vidence-based care and the care actually delivered in
linical practice (1–6). This “voltage drop” from discovery
o application threatens to deprive patients of the benefits
f new treatments. We know that the American College
f Cardiology/American Heart Association (ACC/AHA)
uidelines are not being used as widely as would be optimal.
hysicians report either a lack of guidelines awareness or, at
imes, even apathy in guidelines implementation as they
*Throughout his Presidential year, Dr. Wolk will present ideas important to
college members, in collaboration with key ACC leaders and staff.uggle their fast-paced and highly pressured everyday prac-
ices (7,8). Regardless of the cause, the impact of underuti-
ization of guidelines for effective care is real for patients, as
videnced in studies showing an increasingly strong rela-
ionship between use of evidence-based care practices and
atient outcomes (9,10).
While underuse of proven therapies is a concern, so is the
otential for overuse or misuse when services are ordered for
easons that are not in the best interest of patients. Unwar-
anted tests and therapies can unduly escalate costs to
atients and society. The documentation on the overuse of
ests or interventions in cardiology has been challenging
ecause criteria for appropriateness are inherently subjective.
evertheless, over the past decade there has been a marked
ncrease in the growth of CV imaging services, particularly
n the U.S.
Since 1996, the number of cardiac imaging procedures
illed to Medicare has grown 9% per year, to 10.6 million in
002—or more than one imaging test ordered for every four
edicare beneficiaries. Interpreting such data can be risky,
owever, because they do not necessarily mean that overuse
as occurred. Instead, they may in fact demonstrate better
are for the exploding population of patients with CV
isease.
Other Medicare data, as well as the Dartmouth Atlas of
ardiovascular Health Care, show a striking variability in the
se of cardiac procedures from one part of the U.S. to
nother. Paradoxically, the data also link states having
igher Medicare spending to lower quality of care (11).
tudies also have found that physicians trained in a given
echnique tend to order that procedure more often. True,
his could indicate a potential for “self-referral,” but it could
lso simply show that patients are being referred specifically
o physicians with a known expertise. Finally, explicit
eviews of indications for coronary revascularization proce-
ures have shown relatively modest rates of obviously
nappropriate care (12,13).
Another issue that threatens to tarnish this golden era of
ardiology is the burgeoning cost of new technology. Med-
cal innovations cannot improve patient care if society
annot afford to use them. This might seem to be a
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ity of financial resources is at hand. A recent editorial in the
ew England Journal of Medicine calculates that implantable
efibrillators, left ventricular assist devices, and drug-eluting
tents could add billions to an already strapped national
udget (14). To stave off explicit rationing in medicine,
ardiologists must strive to be mindful of medical costs. We
ust intentionally choose innovative modalities that will
ive us the most “bang for the buck.” Stated simply, we need
o ensure that every procedure we order for our patients is
acked by solid, value-added care evidence.
HE ROLE OF THE ACC IN PROMOTING QUALITY
he revised mission of the ACC, adopted by the Board of
rustees in 2003, is to advocate for optimal patient care
hrough the development and application of clinical practice
uidelines. The major change was to place more emphasis
n proactive efforts to bring evidence-based applications to
he bedside. Our College is dedicated to providing CV
linicians with both the knowledge and tools necessary to
eliver high-quality, safe, and effective care. To this end, the
CC is expanding and improving its quality enhancement
rocesses by:
developing, in partnership with the AHA, cardiovascular
data standards. These sets of standardized nomenclature
and data elements will facilitate communication inside
and outside the profession.
creating ACC/AHA guidelines that provide recommen-
dations for optimal treatment for most CV illnesses, based
on the best available clinical evidence.
frequently updating these guidelines and making them
Internet accessible via www.acc.org, with executive sum-
maries published in JACC.
proactively planning to embed guidelines into electronic
medical records and into admission and discharge sheets
to help us adhere daily to optimal care.
developing, in partnership with the AHA, explicit “per-
formance measure” metrics from the clinical guidelines.
These quality indicators will define instances in which
care should—or should not—be delivered.
undertaking efforts to systematically measure and feed
back CV care patterns to individual centers and providers.
For example, the ACC-National Cardiovascular Data
Registry (NCDR) catheterization and PCI registry en-
ables hospitals to assess their catheterization lab quality by
benchmarking their results against national standards.
Currently, 495 hospitals participate in the registry, with
more than 650,000 PCI procedures recorded (15,16).
developing specific system tools to improve delivery of CV
care with the recently launched web-based CathKit and
our Guidelines Applied in Practice (GAP) initiative.
Indeed, process of care and tool use can improve quality-
of-care indicators (12,17).
working with health care stakeholders to formulate inno-
vative “pay for quality” initiatives, such as the recentlaunch of the Virginia ACC Chapter Quality Hospital
Improvement Project that makes use of ACC-NCDR
data.
Beyond these efforts to ensure broader use of effective
are, the College also has begun to tackle the challenging
ssue of procedural appropriateness directly, addressing po-
ential overuse of diagnostic and therapeutic modalities.
ppropriateness is clearly connected to clinical guidelines
ut has a level of complexity and detail that goes beyond
heir recommendations. It is the ACC’s attempt to define
what to do,” “when to do,” and “how often to do” in the
ontext of local care environments combined with patient
nd family preferences and values. Ideally, criteria for
ppropriateness would encompass “cost effective” and “ben-
fit versus risk” analysis of available care alternatives. They
hould be simple, reliable, valid, and transparent. Answers
o the overuse question will come through the aggressive
romotion of patient care protocols and recommendations
nd by providing physicians with meaningful feedback on
heir care practices relative to national benchmarks.
Some may not see the importance of the College’s efforts
o address appropriateness. Some might argue that explicit
uideline performance indicators can be divisive and prefer
e not enter this arena. However, if we do not lead in this
ffort, others may set criteria that may not be wise either for
s as physicians or for our patients.
Without this critically important initiative, we may be-
ome vulnerable to assertive third-party payers who may
surp our role and deny us our rightful voice in determining
he best way to treat our patients. Attempts already are
eing made to control the rapid rise in costs for imaging and
ther services. Pre-certification, carve-outs of providers,
eduction in payment, and mandatory lab accreditation have
een instituted.
The College recognizes that failure to follow evidence-
ased best practices leads to less-than-optimal patient ben-
fit through inefficient and ineffective use of resources.
lthough we have emphasized areas for improvement in
atient care, we also recognize that the vast majority of
ardiologists provide high-quality care. Our goal is to author
nd adopt the very best evidence-based guidelines and
uality indicators in order to provide our members with as
uch guidance and as many tools necessary to help them in
heir daily practice. If we do not work collectively toward
his result, others surely will step in and fill the void by
onitoring our conduct, using cost-based algorithms rather
han quality as the predominant driver. There is no rationale
or permitting others to assume this function in our place. It
s the role of our profession to self-monitor, critically review,
nd advance our concept of quality. We must be good
tewards of the gifts—and responsibilities—that have been
ntrusted to us.
end correspondence to: Dr. Michael J. Wolk, 520 East 72nd
treet, New York, New York 10021.
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